| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $26.4M | -22.8% |
| R&D Expense | $55.1M | -2.5% |
| SG&A Expense | $30.7M | -7.7% |
| Operating Income | -$74.5M | -7.3% |
| Pre-tax Income | -$71.4M | -11.0% |
| Income Tax | -$9.4M | +31.8% |
| Net Income | -$62.0M | -22.5% |
| EPS (Basic) | -$0.61 | -19.6% |
| EPS (Diluted) | -$0.61 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.6M | +68.7% |
| Accounts Receivable | $5.3M | +37.1% |
| Current Assets | $68.1M | -28.2% |
| Total Assets | $325.6M | -13.2% |
| Current Liabilities | $15.1M | -34.7% |
| Total Liabilities | $37.9M | -37.4% |
| Stockholders' Equity | $287.6M | -8.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.7M | -1790.0% |
| Capital Expenditures | $1.9M | +14.1% |
| Investing Cash Flow | $37.9M | +306.2% |
| Financing Cash Flow | $13.0M | +1559.6% |
| Free Cash Flow | -$41.5M | -6008.8% |
| -19.6% |